Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Capucine Trollet

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Neurology|December 25, 2016
Correlation between PABPN1 genotype and disease severity in oculopharyngeal muscular dystrophyPascale Richard, Capucine Trollet, Tanya Stojkovic, et al.
Current Opinion in Pharmacology|December 25, 2022
Update on anti-fibrotic pharmacotherapies in skeletal muscle diseaseLaura Muraine, Mona Bensalah, Gillian Butler-Browne, et al.
The American Journal of Pathology|September 16, 2022
Dystrophin Restoration after Adeno-Associated Virus U7-Mediated Dmd Exon Skipping Is Modulated by Muscular Exercise in the Severe D2-Mdx Duchenne Muscular Dystrophy Murine ModelAlexandra Monceau, Dylan Moutachi, Mégane Lemaitre, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 28, 2010
Combination of myostatin pathway interference and dystrophin rescue enhances tetanic and specific force in dystrophic mdx miceJulie Dumonceaux, Solenne Marie, Cyriaque Beley, et al.
Human Vaccines & Immunotherapeutics|July 24, 2013
DNA electroporation in rabbits as a method for generation of high-titer neutralizing antisera: examples of the botulinum toxins types A, B, and EAurore Burgain, Alice Rochard, Capucine Trollet, et al.
Human Molecular Genetics|May 31, 2008
RNAi-mediated knockdown of dystrophin expression in adult mice does not lead to overt muscular dystrophy pathologyMohammad M Ghahramani Seno, Ian R Graham, Takis Athanasopoulos, et al.
Frontiers in Cell and Developmental Biology|October 6, 2022
Muscle fibro-adipogenic progenitors from a single-cell perspective: Focus on their "virtual" secretomeElisa Negroni, Maria Kondili, Laura Muraine, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 4, 2008
Codon and mRNA sequence optimization of microdystrophin transgenes improves expression and physiological outcome in dystrophic mdx mice following AAV2/8 gene transferHelen Foster, Paul S Sharp, Takis Athanasopoulos, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 9, 2019
Inhibition of myostatin improves muscle atrophy in oculopharyngeal muscular dystrophy (OPMD)Pradeep Harish, Alberto Malerba, Ngoc Lu-Nguyen, et al.
Human Gene Therapy|April 2, 2011
Delivery of AAV2/9-microdystrophin genes incorporating helix 1 of the coiled-coil motif in the C-terminal domain of dystrophin improves muscle pathology and restores the level of α1-syntrophin and α-dystrobrevin in skeletal muscles of mdx miceTaeyoung Koo, Alberto Malerba, Takis Athanasopoulos, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Neurology|December 25, 2016
Correlation between PABPN1 genotype and disease severity in oculopharyngeal muscular dystrophyPascale Richard, Capucine Trollet, Tanya Stojkovic, et al.
Current Opinion in Pharmacology|December 25, 2022
Update on anti-fibrotic pharmacotherapies in skeletal muscle diseaseLaura Muraine, Mona Bensalah, Gillian Butler-Browne, et al.
The American Journal of Pathology|September 16, 2022
Dystrophin Restoration after Adeno-Associated Virus U7-Mediated Dmd Exon Skipping Is Modulated by Muscular Exercise in the Severe D2-Mdx Duchenne Muscular Dystrophy Murine ModelAlexandra Monceau, Dylan Moutachi, Mégane Lemaitre, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 28, 2010
Combination of myostatin pathway interference and dystrophin rescue enhances tetanic and specific force in dystrophic mdx miceJulie Dumonceaux, Solenne Marie, Cyriaque Beley, et al.
Human Vaccines & Immunotherapeutics|July 24, 2013
DNA electroporation in rabbits as a method for generation of high-titer neutralizing antisera: examples of the botulinum toxins types A, B, and EAurore Burgain, Alice Rochard, Capucine Trollet, et al.
Human Molecular Genetics|May 31, 2008
RNAi-mediated knockdown of dystrophin expression in adult mice does not lead to overt muscular dystrophy pathologyMohammad M Ghahramani Seno, Ian R Graham, Takis Athanasopoulos, et al.
Frontiers in Cell and Developmental Biology|October 6, 2022
Muscle fibro-adipogenic progenitors from a single-cell perspective: Focus on their "virtual" secretomeElisa Negroni, Maria Kondili, Laura Muraine, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 4, 2008
Codon and mRNA sequence optimization of microdystrophin transgenes improves expression and physiological outcome in dystrophic mdx mice following AAV2/8 gene transferHelen Foster, Paul S Sharp, Takis Athanasopoulos, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 9, 2019
Inhibition of myostatin improves muscle atrophy in oculopharyngeal muscular dystrophy (OPMD)Pradeep Harish, Alberto Malerba, Ngoc Lu-Nguyen, et al.
Human Gene Therapy|April 2, 2011
Delivery of AAV2/9-microdystrophin genes incorporating helix 1 of the coiled-coil motif in the C-terminal domain of dystrophin improves muscle pathology and restores the level of α1-syntrophin and α-dystrobrevin in skeletal muscles of mdx miceTaeyoung Koo, Alberto Malerba, Takis Athanasopoulos, et al.
Pageof 7